Bristol-Myers Squibb Completes Acquisition of Inhibitex.

About Bristol-Myers Squibb Bristol-Myers Squibb is certainly a worldwide biopharmaceutical company whose mission is to find, develop and deliver innovative medicines that help sufferers prevail over serious illnesses.. Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc. Bristol-Myers Squibb Business announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc. at a purchase price of $26.00 per share. As of the expiration of the offer, 77,532,611 shares of common stock of Inhibitex were validly tendered and not withdrawn in the tender offer. By the close of business on February 10, 2012, approximately 4,260,705 shares remained at the mercy of guaranteed delivery methods.Although most situations of the condition develop in women over 50 years aged, a small percent are in ladies in the 30s or more youthful. Australian pop singer Kylie Minogue was diagnosed with the disease earlier this full year at the age of 36. Generally breast malignancy is treated with surgery and radiotherapy, hormone and chemotherapy treatment, or a combined mix of them, with respect to the malignancy and stage of the illness. Factors which can increase a woman’s threat of breast cancer include having a mom or close relative with the disease, inherited mutations in the BRCA1 or BRCA2 genes, an early puberty, late menopause and not having any small children. The scholarly study is published in The Lancet medical journal..